Investors & Media

SEC Filings

Document Details

Form
Filing Date
December 4, 2023
Document Date
December 1, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
Viret Jean-Frederic

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com